Multivalvular Disease: Percutaneous Management in 2019 and Beyond

Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Erlebach, Magdalena, Lange, Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Structural
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918484/
https://www.ncbi.nlm.nih.gov/pubmed/31867059
http://dx.doi.org/10.15420/icr.2019.13.R1
_version_ 1783480600900927488
author Erlebach, Magdalena
Lange, Rüdiger
author_facet Erlebach, Magdalena
Lange, Rüdiger
author_sort Erlebach, Magdalena
collection PubMed
description Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.
format Online
Article
Text
id pubmed-6918484
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-69184842019-12-20 Multivalvular Disease: Percutaneous Management in 2019 and Beyond Erlebach, Magdalena Lange, Rüdiger Interv Cardiol Structural Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population. Radcliffe Cardiology 2019-11-18 /pmc/articles/PMC6918484/ /pubmed/31867059 http://dx.doi.org/10.15420/icr.2019.13.R1 Text en Copyright © 2019, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Structural
Erlebach, Magdalena
Lange, Rüdiger
Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_full Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_fullStr Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_full_unstemmed Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_short Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_sort multivalvular disease: percutaneous management in 2019 and beyond
topic Structural
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918484/
https://www.ncbi.nlm.nih.gov/pubmed/31867059
http://dx.doi.org/10.15420/icr.2019.13.R1
work_keys_str_mv AT erlebachmagdalena multivalvulardiseasepercutaneousmanagementin2019andbeyond
AT langerudiger multivalvulardiseasepercutaneousmanagementin2019andbeyond

Ejemplares similares